Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 25 years of experience in analyzing hundreds of companies, especially in Asia. Deep expertise in the following sectors:
- Technology (E-commerce, SaaS, Internet)
- Consumer 
- Special Situations/Deep Value Plays
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Arb Spread Has Opened Today in Classys & Ilooda Merger Swap: Checking Trade Feasibility

Classys (214150 KS): Solid 2Q24 Result Fuelled by Strong Demand for Aesthetic Medical Devices

Classys (214150 KS): Beautiful Journey Continues; Record High Revenue and Operating Profit in 1Q24

Classys: One of Korea's Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends

Classys (214150 KS): 2023 Sales Beat Guidance to Reach Record High; Stellar Performance to Continue

Douglas Research Advisory

Event-Driven

<ul>
<li>On 25 June, Classys (214150 KS) announced a merger with Ilooda (164060 KS). The merger ratio is set at 0.1405237 to 1 for Classys and Ilooda.</li>
<li>This merger aims to combine Classys’ expertise in high-intensity focused ultrasound (HIFU) with Ilooda’s in micro-needle radio frequency (RF) and laser technologies.</li>
<li>We have a positive view of this merger between Classys and Ilooda. This merger is likely to <em><strong>reduce the overall competition</strong></em> in the aesthetics devices market in Korea.</li>
</ul>


On 25 June, Classys (214150 KS) announced a merger with Ilooda (164060 KS). The merger ratio is set at 0.1405237 to 1 for Classys and Ilooda.
This merger aims to combine Classys’ expertise in high-intensity focused ultrasound (HIFU) with Ilooda’s in micro-needle radio frequency (RF) and laser technologies.
We have a positive view of this merger between Classys and Ilooda. This merger is likely to reduce the overall competition in the aesthetics devices market in Korea.


Merger Between Classys and Ilooda Likely to Reduce Local Competition